Aquaporin-4 IgG: Overview and future perspectives

Neurology Asia

Volumn 13, Issue 2, 2008, Pages 179-183

  Kermode, Allan G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; UNCLASSIFIED DRUG;

DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HUMAN; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PHENOTYPIC VARIATION; PROGNOSIS; PROTEIN LOCALIZATION; RECURRENCE RISK; REVIEW; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 67649313877     PISSN: 18236138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004; 364:2106-12.
2. Wingerchuk DM, Lennon VA, Luchinetti CF. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-15.
3. Marignier R, de Seze J, Vukusic S, et al. NMO-IgG and Devic's neuromyelitis optica: A French experience. Mult Scler 2008; 14:440-5.
4. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58:840-6.
5. Kikuchi S, Fukazawa T. "OS MS is NMO, but not MS": Confirmed by NMO-IgG? Lancet Neurol 2005; 4: 594-5.
6. Weinshenker BG, Wingerchuk DM, Nakashima I, et al. OS is NMO, but not MS: Proven clinically and pathologically. Lancet 2006; 5:110-11.
7. McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008; 71: 93-100.
8. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53(5):1107-14.
9. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007; 130:1206-23.
10. Hayakawa S, Morri M, Okuta A, et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme linked immunosorbent assay. J Neuroimmunol 2008; 196:181-7.
11. Pittock SJ. Neuromyelitis optica: A new perspective. Semin Neurol 2008; 28:95-104.
12. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63:390-6.
13. Galetta SL, Bennett J. Neuromyelitis optica is a variant of multiple sclerosis. Arch Neurol 2007; 64:901-3.
14. Bouchard JPL, Thibault M, Duquette P, et al. Screening for aquaporin-4 IgG antibodies in French-Canadian patients with unusual myelitis, optic neuritis or both. WCTRIMS 2008, Poster 301.
15. Tan K, Shuguna M, Goh KY, SA Lim SA, Umapathi T. The prevalence of NMO-IgG in Singapore - A pilot study. Neurol Asia 2008; 13:205-6.
16. Pandit L. Neuromyelitis optica antibody (NMO IgG) status in Indian patients with multiple sclerosis and allied demyelinating disorders. Neurol Asia 2008; 13:175-8.
17. Wu JS, Matsushita T, Carroll WM, et al. Low sensitivity of anti-aquaporin-4 antibody in multiple sclerosis, longitudinally extensive cord lesions and neuromyelitis optica in Australia. Neurol Asia 2007; 12:149-50.
18. Horga A, Hemmer B, Edan G, et al. antibodies to aquaporin-4 in patients with a clinically isolated syndrome: Analysis from the BENEFIT study. WCTRIMS 2008, Poster 67, Mult Scler (In press).
19. Matiello M, Lennon VA, Jacob A, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008; 70:2197-200.
20. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006; 59:566-9.
21. Giovannoni G. To test or not to test? NMO-IgG and optic neuritis. Neurology 2008; 70: 2192-3.
22. Jarius S, Aboul-Enein F, Waters P, et al. Antibody to aquaporin-4 in the long term course of neuromyelitis optica. Brain 2008; 131:3072-80.
23. Amiry-Moghaddan M, Ottersen OP. The molecular basis of water transport in the brain. Nature Reviews Neuroscience 2003; 4:991-1001.
24. Pittock SJ, Weinshenker BG, Luchinetti CF, et al. Neuromyelitis brain lesions localized at sites of high aquaporin-4 expression. Arch Neurol 2006; 63:390-6.
25. Roemer SF, Parisi JE, Lennon VA, et al. Pattern specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007; 130:1194-205.